moxifloxacin has been researched along with Mycoplasma dispar Infection in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D | 1 |
| Ekambaram, R; Raghunathan, M; Raghunathan, R; Rao, SS | 1 |
| He, YS; Ji, J; Liu, G; Qian, SY; Yang, M | 1 |
| Chen, Y; Chu, S; Wang, J; Yan, C; Yu, L | 1 |
| Liu, J; Long, X; Luo, H; Pan, X; Shen, F; Wang, S; Wu, J; Yao, L; Yuan, T | 1 |
| Al Yazidi, LS; Britton, P; Hameed, H; Herath, A; Kesson, A; Pandit, C | 1 |
| Gu, L; Jia, S; Lai, GX; Liu, W; Wang, AM; Wen, W; Xia, WJ; Yu, GQ; Yu, P; Zeng, H | 1 |
| Kazama, I; Nakajima, T | 1 |
| Ci, X; Ding, J; Gao, Y; Shangguan, Z; Sun, Q; Yi, L; Zhan, A; Zhang, M; Zhao, R | 1 |
| Megjhani, M; Shahzad, S; Suryanarayanan, M; Vasudevan, VP | 1 |
| Marko, PB; Miljković, J; Trčko, K | 1 |
| Hu, Y; Shen, K; Shen, Y; Zhang, J | 1 |
| Kazama, I; Nakajima, T; Tamada, T | 1 |
13 other study(ies) available for moxifloxacin and Mycoplasma dispar Infection
| Article | Year |
|---|---|
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycoplasma hominis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolines | 2009 |
Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Drug Resistance, Bacterial; Humans; Moxifloxacin; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Retrospective Studies | 2023 |
The differential diagnosis of pneumonia in two patients infected by atypical pathogens.
Topics: Adolescent; Adult; COVID-19; Diagnosis, Differential; DNA, Bacterial; Feces; Female; Humans; Male; Metagenomics; Moxifloxacin; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Sputum; Young Adult | 2021 |
Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Coinfection; Female; Fluoroquinolones; Humans; Immunoglobulins; Influenza A Virus, H7N9 Subtype; Influenza, Human; Methylprednisolone; Moxifloxacin; Mycoplasma pneumoniae; Oseltamivir; Pneumonia, Mycoplasma | 2018 |
A 6-year-old girl with severe, focal Mycoplasma pneumoniae pneumonia.
Topics: Anti-Bacterial Agents; Child; Female; Humans; Lung; Moxifloxacin; Mycoplasma pneumoniae; Patient Acuity; Pleural Effusion; Pneumonia, Mycoplasma; Radiography, Thoracic; Respiration, Artificial | 2019 |
Outbreak of mycoplasmal round pneumonia in an adult population: A case series.
Topics: Agglutination Tests; Anti-Bacterial Agents; China; Community-Acquired Infections; Diagnosis, Differential; Disease Outbreaks; Humans; Male; Moxifloxacin; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2018 |
Dual infection of Mycoplasma pneumoniae and Chlamydophila pneumoniae in patients with atopic predispositions successfully treated by moxifloxacin.
Topics: Adolescent; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Dermatitis, Atopic; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pneumonia, Mycoplasma; Remission Induction; Young Adult | 2014 |
Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibodies, Bacterial; China; Community-Acquired Infections; Female; Fluoroquinolones; Hospitalization; Humans; Lung; Male; Middle Aged; Moxifloxacin; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Prevalence; Radiography; Treatment Outcome; Young Adult | 2014 |
Mycoplasma pneumoniae bronchiolitis mimicking asthma in an adult.
Topics: Adult; Albuterol; Anti-Infective Agents; Asthma; Aza Compounds; Bronchiolitis; Bronchodilator Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Mycoplasma; Quinolines; Steroids | 2012 |
Leukocytoclastic vasculitis induced by Mycoplasma pneumoniae infection.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Humans; Male; Moxifloxacin; Pneumonia, Mycoplasma; Quinolines; Radiography; Vasculitis, Leukocytoclastic, Cutaneous | 2012 |
Combination therapy with immune-modulators and moxifloxacin on fulminant macrolide-resistant Mycoplasma pneumoniae infection: A case report.
Topics: Anti-Bacterial Agents; Aza Compounds; Child; Disease Progression; Drug Therapy, Combination; Fluoroquinolones; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Moxifloxacin; Pneumonia, Mycoplasma; Pulse Therapy, Drug; Quinolines | 2013 |
Resolution of migratory pulmonary infiltrates by moxifloxacin in a patient with dual infection of Mycoplasma pneumoniae and Bordetella pertussis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Mycoplasma; Quinolines; Whooping Cough | 2012 |